Nombre del producto:3-methyl-N-[(1r,3r)-3-(4-fluorophenyl)cyclobutyl]oxetane-3-carboxamide

IUPAC Name:3-methyl-N-[(1r,3r)-3-(4-fluorophenyl)cyclobutyl]oxetane-3-carboxamide

CAS:2248542-05-2
Fórmula molecular:C15H18FNO2
Pureza:95%+
Número de catálogo:CM1022638
Peso molecular:263.31

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2248542-05-2
Fórmula molecular:C15H18FNO2
Punto de fusión:-
Código de sonrisas:CC1(COC1)C(=O)N[C@H]1C[C@@H](C1)C1=CC=C(F)C=C1
Densidad:
Número de catálogo:CM1022638
Peso molecular:263.31
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
Oxetanes
Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.

Related Products